Expression of LPAAT-β in ovarian and endometrial tumors
| Tumor type . | No. of cases . | LPAAT-β+ . | LPAAT-β− . | P* . | ||||
|---|---|---|---|---|---|---|---|---|
| Ovarian | ||||||||
| All ovarian tumors | 87 (100%) | 38 (44%) | 49 (56%) | |||||
| All carcinomas | 70 (100%) | 32 (46%) | 8 (54%) | |||||
| Serous | 18 (100%) | 12 (67%) | 6 (33%) | |||||
| Clear cell | 15 (100%) | 10 (67%) | 5 (33%) | |||||
| Endometrioid | 13 (100%) | 7 (54%) | 6 (46%) | |||||
| Mucinous | 17 (100%) | 1 (6%) | 16 (94%) | |||||
| Mixed histology | 7 (100%) | 2 (29%) | 5 (71%) | |||||
| Borderline (low malignant potential) | 17 (100%) | 6 (35%) | 11 (65%) | <0.001† | ||||
| Normal ovarian | ||||||||
| Epithelium | 14 (100%) | 0 (0%) | 14 (100%) | |||||
| Endometrial | ||||||||
| Endometrioid | 54 (100%) | 7 (13%) | 47 (87%) | |||||
| Serous | 16 (100%) | 8 (50%) | 8 (50%) | 0.0036‡ | ||||
| Clear cell | 11 (100%) | 5 (45%) | 6 (55%) | 0.0235‡ | ||||
| Malignant mixed Mullerian tumors | 11 (100%) | 8 (73%) | 3 (27%) | 0.0001‡ | ||||
| FIGO I and II | 26 (100%) | 3 (11%) | 23 (89%) | |||||
| FIGO III | 70 (100%) | 26 (37%) | 44 (63%) | 0.0229§ | ||||
| Tumor type . | No. of cases . | LPAAT-β+ . | LPAAT-β− . | P* . | ||||
|---|---|---|---|---|---|---|---|---|
| Ovarian | ||||||||
| All ovarian tumors | 87 (100%) | 38 (44%) | 49 (56%) | |||||
| All carcinomas | 70 (100%) | 32 (46%) | 8 (54%) | |||||
| Serous | 18 (100%) | 12 (67%) | 6 (33%) | |||||
| Clear cell | 15 (100%) | 10 (67%) | 5 (33%) | |||||
| Endometrioid | 13 (100%) | 7 (54%) | 6 (46%) | |||||
| Mucinous | 17 (100%) | 1 (6%) | 16 (94%) | |||||
| Mixed histology | 7 (100%) | 2 (29%) | 5 (71%) | |||||
| Borderline (low malignant potential) | 17 (100%) | 6 (35%) | 11 (65%) | <0.001† | ||||
| Normal ovarian | ||||||||
| Epithelium | 14 (100%) | 0 (0%) | 14 (100%) | |||||
| Endometrial | ||||||||
| Endometrioid | 54 (100%) | 7 (13%) | 47 (87%) | |||||
| Serous | 16 (100%) | 8 (50%) | 8 (50%) | 0.0036‡ | ||||
| Clear cell | 11 (100%) | 5 (45%) | 6 (55%) | 0.0235‡ | ||||
| Malignant mixed Mullerian tumors | 11 (100%) | 8 (73%) | 3 (27%) | 0.0001‡ | ||||
| FIGO I and II | 26 (100%) | 3 (11%) | 23 (89%) | |||||
| FIGO III | 70 (100%) | 26 (37%) | 44 (63%) | 0.0229§ | ||||